MyoStrain

DIAGNOSTIC_TEST2 trials

Sponsors

Myocardial Solutions

Conditions

CardiotoxicityChemotherapeutic ToxicityCoronary Artery DiseaseHeart FailureMyocardial DysfunctionMyocardial Ischemia

Unknown Phase

MyoStrain CMR Testing of Ischemia With Low Levels of Stress

CompletedNCT03543241

Myocardial SolutionsCoronary Artery Disease, Myocardial Dysfunction, Myocardial Ischemia

Start: 2017-11-08End: 2018-10-18Updated: 2018-12-19

MyoStrain CMR for the Detection of Cardiotoxicity

CompletedNCT03543228

Myocardial SolutionsCardiotoxicity, Chemotherapeutic Toxicity, Heart Failure

Start: 2017-08-01End: 2020-01-31Updated: 2021-06-25

Related Papers

Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up

Circulation Cardiovascular Imaging2021-06-0165 citations

Abstract P5-14-18: Cardioprotective therapy in breast cancer patients with subclinical and clinical cardiotoxicty

Cancer Research2020-02-15

P3118CMR Fast-SENC intramyocardial LV & RV segmental strain detects cardiotoxicity during oncology treatment and impact of cardioprotection therapy before echocardiography

European Heart Journal2019-10-012 citations

P3554CMR Fast-SENC intramyocardial LV & RV segmental strain helps manage cardioprotective therapy in patients exhibiting cardiotoxicity during cancer treatment

European Heart Journal2019-10-01